Business Context and Reporting Period
This Form 8-K Current Report was filed by Novavax, Inc. on March 7, 2022, covering the event date of March 5, 2022. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol NVAX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate governance event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director:
- Rajiv I. Modi, Ph.D. notified the Board of Directors of his resignation, effective immediately on March 5, 2022.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the director's resignation.
Investor Verification Checklist
- Confirm the effective date of Rajiv I. Modi, Ph.D.'s resignation (March 5, 2022).
- Review the composition of the Board of Directors following this departure.
- Check for any subsequent filings regarding the appointment of a replacement director.